Zurueck zur Suche

Reporte zur Charge UT7378MA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WA 19

VAERS 2482603

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
0,5
Geschlecht
F
Eingang
19.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

FLUZONE PFS, that was expired was administered to patient with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case US-SA-2022SA417187(CLUSTER). This case involves a 6 months old female patient who was administered INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT], that was expired with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), HIB VACCINE CONJ (MENIGOCOCCAL PROTEIN), PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (VAXELIS); PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR); and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ), all for Immunisation. On 07-Oct-2022, the patient was administered expired INFLUENZA QUADRIVAL A-B VACCINE with an unknown dose once (lot UT7378MA; expiry date: 30-Jun-2022; strength: standard) via intramuscular route in the left vastus lateralis for prophylactic vaccination (expired product administered)(latency same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
VAXELIS; PREVNAR; ROTATEQ
Allergien
-
Vorherige Impfungen
-

VAERS 2482602

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
1,0
Geschlecht
M
Eingang
19.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

fluzone pfs, that were expired was administered with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health care professional. This case is linked to cases 2022SA418835(CLUSTER), 2022SA417297(CLUSTER), 2022SA419920(CLUSTER), 2022SA418873(CLUSTER), 2022SA419928(CLUSTER), 2022SA419132(CLUSTER), 2022SA419111(CLUSTER), 2022SA417976(CLUSTER), 2022SA417246(CLUSTER), 2022SA417992(CLUSTER), 2022SA417624(CLUSTER), 2022SA419912(CLUSTER), 2022SA417187(CLUSTER), 2022SA417608(CLUSTER) and 2022SA420010(CLUSTER). This case involves a 1 year old male patient and fluzone pfs, that were expired was administered with no reported adverse event. (Influenza quadrival A-B vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant medications included hepatitis A vaccine (HEPA [Hepatitis A vaccine]) for prophylactic vaccination; pneumococcal CONJ 7V (CRM197) (Prevnar) for prophylactic vaccination; and measles vaccine, mumps vaccine, rubella vaccine (MMR) for prophylactic vaccination. On 07-Oct-2022, the patient received suspect influenza quadrival A-B vaccine standard at a dose of 0.5 ml once (lot UT7378MA, expiry date- 30-Jun-2022) via intramuscular route in the left vastus lateralis for immunization. On 07-Oct-2022 the patient received fluzone pfs, that were expired was administered with no reported adverse event (expired product administered) (latency : same day) following the administration of influenza quadrival A-B vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
HEPA [HEPATITIS A VACCINE]; PREVNAR; MMR
Allergien
-
Vorherige Impfungen
-

VAERS 2482601

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
6,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

inadvertently given expired product, with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA419169(CLUSTER) and 2022SA420010(CLUSTER). This case involves a 6 years old female patient who was inadvertently given expired product, with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5 mL total dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (formulation and strength not reported; lot UT7378MA and expiry date: 30-Jun-2022) via intramuscular route in the left deltoid for prophylactic vaccination. On an unknown date, the patient was inadvertently given expired product, with no reported adverse event (expired product administered) (latency: same day) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482600

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
2,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

inadvertently given expired product with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA419169(CLUSTER) and 2022SA420010(CLUSTER). This case involves a 2 years old female patient who was inadvertently given expired product with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received 0.5 ml total dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7378MA and expiry date: 30-Jun-2022) via intramuscular route in the right deltoid for prophylactic vaccination. On 07-Oct-2022, (latency: same day) the patient was inadvertently given expired product with no reported adverse event (expired product administered) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01314490:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482599

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
16,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

fluzone pfs, that was expired was administered, with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves a 16-year-old female patient to whom INFLUENZA QUADRIVAL A-B VACCINE [Fluzone Qiv], that was expired was administered, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received suspect INFLUENZA QUADRIVAL A-B VACCINE at a dose 0.5ml total (strength: standard; formulation: unknown), Drug Treatment Duration: not applicable (NA) (lot number: UT7378MA and expiry date: 30-Jun-2022) via intramuscular route in the left deltoid for Immunization and on the same day, fluzone pfs, that was expired was administered, with no reported adverse event (expired product administered). This situation is reported as a medication error due to inadvertently given expired product. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482597

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
1,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

FLUZONE PFS, that were expired was administered with no adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health care professional. This case is linked to cases 2022SA418835(CLUSTER), 2022SA417297(CLUSTER), 2022SA419920(CLUSTER), 2022SA418873(CLUSTER), 2022SA419928(CLUSTER), 2022SA419132(CLUSTER), 2022SA419111(CLUSTER), 2022SA417976(CLUSTER), 2022SA417246(CLUSTER), 2022SA417992(CLUSTER), 2022SA417624(CLUSTER), 2022SA419912(CLUSTER), 2022SA417187(CLUSTER), 2022SA417608(CLUSTER) and 2022SA419169 (CLUSTER). This case involves a 1 year old female patient and Fluzone QIV PFS (Influenza quadrival A-B vaccine [Fluzone QIV], that were expired was administered with no reported adverse event. The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant medications included hepatitis a vaccine for prophylactic vaccination; pneumococcal CONJ 7V (CRM197) (Prevnar) for prophylactic vaccination; and measles vaccine, mumps vaccine, rubella vaccine (MMR) for prophylactic vaccination. On 07-Oct-2022, the patient had received a dose of suspect influenza quadrival A-B vaccine Suspension for injection standard at a dose of 0.5 ml total (lot UT7378MA, expiry date- 30-Jun-2022) via intramuscular route in the left vastus lateralis for immunization. On 07-Oct-2022 the patient received fluzone pfs, that were expired was administered with no reported adverse event (expired product administered) (latency : same day) following the administration of influenza quadrival A-B vaccine. Action taken - not applicable. Outcome - Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR; HEPATITIS A VACCINE; MMR
Allergien
-
Vorherige Impfungen
-

VAERS 2481271

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
12,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Fluzone PFS, that were expired was administered to patient with no reported adverse event.; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 years old female patient who was administered expired Influenza Quadrival A-B Vaccine (Fluzone Quadrivalent) with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received a dose of 0.5 mL frequency: once of suspect influenza quadrival A-B vaccine (with lot UT7378MA, expiry date: 30-Jun-2022) via intramuscular route in the left deltoid for prophylaxis. On 07-Oct-2022 (latency: same day) the patient was administered Fluzone PFS, that were expired with no reported adverse event (expired product administered). No lab data was reported. Action taken : Not Applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481270

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
2,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

expired Fluzone vaccine was administered with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2022SA418873(CLUSTER). This case involves a 2 years old female patient to whom expired INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-OCT-2022, the patient received 0.5 ml of expired INFLUENZA QUADRIVAL A-B VACCINE with no reported adverse event (expired product administered) (lot UT7378MA and expiry date- 30-Jun-2022) via intramuscular route in unknown administration site for immunization or TB test. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481269

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
8,0
Geschlecht
M
Eingang
18.10.2022
Impfdatum
-
Beginn
07.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

FLUZONE PFS, that were expired was administered with no reported Adverse Event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 8 years old male patient who was administered expired influenza quadrival A-B vaccine [Fluzone QIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received suspect influenza quadrival A-B vaccine suspension for injection standard at a dose of 0.5 ml once (lot UT7378MA, expiry date- 30-Jun-2022) via intramuscular route in the right deltoid for immunization. On 07-Oct-2022 the patient was administered expired influenza quadrival A-B vaccine with no reported adverse event (expired product administered) (unknown latency) following the administration of vaccine. Action taken with influenza quadrival A-B vaccine was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481268

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
5,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

inadvertently given expired product, with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves a 5-year-old female patient to whom inadvertently given expired vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV], with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received 0.5ml total dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (strength; standard; formulation: unknown) (lot number: UT7378MA and expiry date: 30-Jun-2022) Drug Treatment Duration: not applicable (NA) via intramuscular route in the left deltoid for Immunization and on the same day to the patient inadvertently given expired product, with no reported adverse event (expired product administered). This situation is reported as a medication error. Action taken was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01314490:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479915

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
0,8
Geschlecht
M
Eingang
17.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Expired product administered

Symptomtext

nadvertently given expired product with no reported adverse event; nadvertently given expired product with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA419169(CLUSTER) and 2022SA420010(CLUSTER). This case involves a 10 months old male patient who was inadvertently given expired product with no reported adverse event ,after receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received a total dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7378MA and expiration date: 30-Jun-2024) at a dose of 0.5ml once via intramuscular route in the vastus lateralis for immunization. On 07-Oct-2022(latency: same day), the patient was inadvertently given expired product with no reported adverse event (expired product administered) (accidental exposure to product) following the administration. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. Outcome: unknown for both events This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479853

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
2,0
Geschlecht
M
Eingang
17.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

expired was administered with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 years old male patient who was inadvertently given expired product influenza quadrival a-b vaccine [Fluzone QIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022,the patient received a dose of suspect influenza quadrival a-b vaccine Suspension for injection (lot UT7378MA, expiry date: 30-JUN-2022) 0.5ml (milliliter) total at once (strength: unknown) via intramuscular route in the left vastus lateralis for Immunization. On 07-Oct-2022 the patient was inadvertently given expired product with no reported adverse event (expired product administered) same day following the administration of vaccine. No lab data reported. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479852

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
7,0
Geschlecht
M
Eingang
17.10.2022
Impfdatum
-
Beginn
07.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

reported as a medication error due to inadvertently given expired product, 30Jun2022 with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA419169(CLUSTER) and 2022SA420010(CLUSTER). This case involves a 7 years old male patient who experienced reported as a medication error due to inadvertently given expired product, 30jun2022 with no reported adverse event while receiving vaccine influenza quadrival a-b vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect influenza quadrival a-b vaccine at dose of 0.5 mL 1X lot UT7378MA, Expiry date: 30-Jun-2022 via intramuscular route in the right deltoid for Immunization. On 07-Oct-2022 the patient developed a non-serious reported as a medication error due to inadvertently given expired product, 30jun2022 with no reported adverse event (expired product administered) (unknown latency) following the administration of influenza quadrival a-b vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event (reported as a medication error due to inadvertently given expired product, 30Jun2022 with no reported adverse event). At time of reporting, the outcome was Unknown for the event reported as a medication error due to inadvertently given expired product, 30jun2022 with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479851

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge UT7378MA

gering
Staat
WA
Alter
11,0
Geschlecht
M
Eingang
17.10.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

inadvertently given expired product with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2022SA419169(CLUSTER). This case involves a 11 years old male patient who was inadvertently given expired product influenza usp trival a-b subvirion no preservative vaccine [Fluzone] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect influenza usp trival a-b subvirion no preservative vaccine Suspension for injection (lot: UT7378MA, expiry date: 30-Jun-2022) (Strength: unknown) 300mg total at once via intramuscular route in the left deltoid for immunization. On an unknown date the patient was inadvertently given expired product with no reported adverse event (expired product administered) (unknown latency) following the administration of vaccine. No lab data reported. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479849

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
13,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

inadvertently given expired product with no reported adverse event; inadvertently given expired product with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA418835(CLUSTER), 2022SA419132(CLUSTER) and 2022SA418873(CLUSTER). This case involves a 13 years old female patient who was inadvertently given expired product with no reported adverse event ,after receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received a total dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7378MA and expiration date: 30-Jun-2024) at a dose of 0.5ml once via intramuscular route in the left deltoid for immunization. On 07-Oct-2022(latency: same day), the patient was inadvertently given expired product with no reported adverse event (expired product administered) (accidental exposure to product) following the administration. Action taken:not applicable. It was not reported if the patient received a corrective treatment for the events. Outcome: unknown for both events This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479469

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
0,6
Geschlecht
M
Eingang
15.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

fluzone pfs, that were expired was administered,with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case from a other healthcare professional. This case is linked to cases 2022SA417187(CLUSTER) and 2022SA418817(CLUSTER). This case involves a 7 months old male patient who whom expired Influenza Quadrival A-B Vaccine [Fluzone QIV] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal Vaccine CONJ 7V (CRM197) (Prevnar); Hepatitis A Vaccine (Hepatitis A) and Measles Vaccine, Mumps Vaccine, Rubella Vaccine (MMR) for Immunisation. On 07-Oct-2022, the patient received 0.5 ml of expired Influenza Quadrival A-B Vaccine with no reported adverse event (expired product administered) (lot UT7378MA and expiry date- 30-Jun-2022) via intramuscular route in unknown administration site for immunization or TB test. Action taken: Not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR; HEPATITIS A; MMR
Allergien
-
Vorherige Impfungen
-

VAERS 2479468

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
2,0
Geschlecht
M
Eingang
15.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

inadvertently given expired product with no adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious received from a other health professional. This case involves a 2 years old male patient who was given an expired influenza quadrival a-b vaccine [fluzone qiv] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, (latency: same day) the patient inadvertently received a 0.5 ml (once) dose of expired influenza quadrival a-b vaccine with no adverse event (expired product administered) (lot UT7378MA, expiry date: 30-Jun-2022) via intramuscular route in the left vastus lateralis for immunization. Action taken: not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479467

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
3,0
Geschlecht
M
Eingang
15.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

FLUZONE PFS, that were expired was administered to 19 patients; Initial information was received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case is linked to case US-SA-2022SA417187(CLUSTER). This case involves a 3 years old male patient and reporter reported Influenza quadrival A-B vaccine [Fluzone QIV] that were expired was administered to 19 patients. No other vaccines. The patient's past medical history, medical treatment(s) and family history were not provided. On 07-Oct-2022, the patient received a total dose of suspect Influenza quadrival A-B vaccine suspension for injection 0.5 ml (lot UT7378MA, expiration date: 30-Jun-2022) via intramuscular route in the left deltoid for immunization which was expired (expired product administered) (latency: same day). Action taken: Not applicable. Corrective treatment: Not reported. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479465

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7378MA

gering
Staat
WA
Alter
5,0
Geschlecht
F
Eingang
15.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

inadvertently given expired product with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 5 years old female patient who was inadvertently given expired product with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2022, the patient received a dose of 0.5 ml of suspect INFLUENZA QUADRIVAL A-B VACCINE (formulation, strength: unknown) lot UT7378MA, expiration date: 30-Jun-2022 via intramuscular route in the thigh nos (not other wise specified) (vastus lateralis) as Immunization On 07-OCT-2022 the patient was inadvertently given expired product with no reported adverse event (expired product administered) same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (inadvertently given expired product with no reported adverse event). At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-